LONG-TERM CORRECTION OF NEUTROPENIA IN FELTYS SYNDROME WITH GRANULOCYTE-COLONY-STIMULATING FACTOR

被引：16

作者：

WANDT, H

SEIFERT, M

FALGE, C

GALLMEIER, WM

机构：

[1] 5. Medizinische Klinik, Klinikum Nürnberg, Institut für medizinische Onkologie und Hämatologie, Nürnberg 90, W-8500

来源：

ANNALS OF HEMATOLOGY | 1993年 / 66卷 / 05期

关键词：

G-CSF; NEUTROPENIA; FELTYS SYNDROME;

D O I：

10.1007/BF01738478

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Neutropenia in Felty's Syndrome predisposes patients to recurrent bacterial infections. We have treated a patient for more than one year with G-CSF and ascertained that this growth factor can savely correct neutropenia over a long periode of time. G-CSF may constitute a new agent for the treatment and prophylaxis of infection in Felty's syndrome.

引用

页码：265 / 266

页数：2

共 50 条

[21] Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor
Hellmich, B
Schnabel, A
Gross, WL
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1999, 29 (02) : 82 - 99
[22] RICHTERS-SYNDROME SHOWING PRONOUNCED LYMPHADENOPATHY IN RESPONSE TO ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR
KAWACHI, Y
OZAKI, S
SAKAMOTO, Y
UCHIDA, T
MORI, M
SETSU, K
TANI, K
ASANO, S
LEUKEMIA & LYMPHOMA, 1994, 13 (5-6) : 509 - 514
[23] MECHANISM OF ENHANCEMENT OF NEUTROPHIL SURVIVAL BY GRANULOCYTE-COLONY-STIMULATING FACTOR AND ADENINE
ADACHI, S
KUBOTA, M
WAKAZONO, Y
HIROTA, H
MATSUBARA, K
KUWAKADO, K
AKIYAMA, Y
MIKAWA, H
EXPERIMENTAL HEMATOLOGY, 1993, 21 (09) : 1213 - 1218
[24] DEVELOPMENT OF INTERSTITIAL PNEUMONITIS DURING TREATMENT WITH GRANULOCYTE-COLONY-STIMULATING FACTOR
KATOH, M
SHIKOSHI, K
TAKADA, M
UMEDA, M
TSUKAHARA, T
KITAGAWA, S
SHIRAI, T
ANNALS OF HEMATOLOGY, 1993, 67 (04) : 201 - 202
[25] LONG-TERM SAFETY OF TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF) IN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIAS
BONILLA, MA
DALE, D
ZEIDLER, C
LAST, L
REITER, A
RUGGEIRO, M
DAVIS, M
KOCI, B
HAMMOND, W
GILLIO, A
WELTE, K
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (04) : 723 - 730
[26] Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?
Martino, Massimo
Fedele, Roberta
Massara, Elisabetta
Recchia, Anna Grazia
Irrera, Giuseppe
Morabito, Fortunato
EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (05) : 609 - 621
[27] A PROSPECTIVE EVALUATION OF THE ACTIVITY OF HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR ON THE PREVENTION OF CHEMOTHERAPY-RELATED NEUTROPENIA IN PATIENTS WITH ADVANCED-CARCINOMA
GEBBIA, V
TESTA, A
VALENZA, R
BORSELLINO, N
CIPOLLA, C
CANNATA, G
CURTO, G
LATTERI, M
FLORENA, M
GEBBIA, N
JOURNAL OF CHEMOTHERAPY, 1993, 5 (03) : 186 - 190
[28] SUCCESSFUL TREATMENT OF NEUTROPENIA IN T-LGL LEUKEMIA (T-GAMMA-LYMPHOCYTOSIS) WITH GRANULOCYTE-COLONY-STIMULATING FACTOR
WEIDE, R
HEYMANNS, J
KOPPLER, H
TIEMANN, M
HUSS, B
PFLUGER, KH
HAVEMANN, K
ANNALS OF HEMATOLOGY, 1994, 69 (03) : 117 - 119
[29] Correction of neutropenia following treatment with granulocyte colony-stimulating factor results in a decreased frequency of infections in Shwachman's syndrome
vanderSande, FM
Hillen, HFP
NETHERLANDS JOURNAL OF MEDICINE, 1996, 48 (03) : 92 - 95
[30] Neonatal neutropenia, nosocomial infection and granulocyte-colony stimulating factor
Escande, B
Kuhn, P
Gaugler, C
Messer, J
ARCHIVES DE PEDIATRIE, 2003, 10 (02): : 93 - 95

← 1 2 3 4 5 →